MedPath

Clinical efficacy evaluation of Huoxiang Zhengqi water in the treatment of children's spleen and stomach diseases by percutaneous (navel) administration -- an observational study

Phase 4
Recruiting
Conditions
Spleen and stomach diseases in children
Registration Number
ITMCTR2200006436
Lead Sponsor
Jiangxi University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1)Subjects met diagnostic criteria.
2)Subject age: 6 months-18 years old.
3)No other transdermal administration or systemic therapy was received prior to inclusion in the study.

Exclusion Criteria

1) Those who have a history of allergy to Huoxiangzhengqi water/liquid;
2) Patients with cognitive dysfunction, disturbance of consciousness, mental illness, reading dysfunction or language and communication dysfunction; patients with other serious diseases, such as malignant tumors, liver and kidney insufficiency, cardiovascular and cerebrovascular diseases, etc.;
3) Participants in other clinical trials.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TCM syndrome score;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath